ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 252

Preliminary Validation of the Michigan Body Map

Chad M. Brummett1, Jenna Goesling2, Rishi Bakshi3, Jennifer Wolfe4, Stephanie Moser5, David A. Williams6 and Afton L. Hassett7, 1Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, 2Department of Anesthesiology, University of Michigan Health System, Ann Arbor, MI, 3Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, 4Anesthesiology, University of Michigan Health System, Ann Arbor, MI, 5Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, 6Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, 7Anesthesiology, University of Michigan, Ann Arbor, MI

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Assessment, Body image, fibromyalgia, pain and questionnaires

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pain: Basic and Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose

One of the hallmark features of fibromyalgia and other centralized pain states is widespread body pain.  We developed the Michigan Body Map (MBM) to assess widespread body pain in clinical care and in epidemiological studies.  The MBM is a one-sided body image with check boxes for 35 body areas and a box for “No Pain.”  The aim of the present study was to assess patients’ understanding of and accuracy when completing the MBM, as well as to assess preference when compared to the 2011 Survey Criteria for Fibromyalgia widespread pain index (WPI) and the body map from the Brief Pain Inventory (BPI).

Methods

85 patients from the University of Michigan’s Physical Medicine and Rehabilitation Spine Center were included in this study.  Written informed consent was obtained. The first phase (n=25) assessed how well participants understood the questionnaire and concurrent validity when compared to a standardized verbal assessment.  In the second phase, the MBM’s reliability was assessed using a test-retest assessment 1-2 weeks after the first assessment (n=20).  In the third phase, participants were randomized to complete the MBM and either the WPI (n = 20) or BPI (n = 20) to assess construct validity and were also asked preference questions about the body maps. 

Results

In the first phase, participants completed the MBM quickly (76.8+/- 64.5 sec).  The majority of participants correctly noted right and left, marked only areas of chronic pain (3 months or more) , and felt that the measure allowed them to note all of their areas of pain (Table 1).  Of the 875 potential check boxes (25 patients x 35 body areas), 63 (7.2%) were incorrectly endorsed as either missed or reversed right/left.  In the second phase, the majority of participants had slight discrepancies in the test-retest (ICC = .60, median 1.5 body areas different); however, these differences did not lead to significant changes in the calculated widespread pain score.  In the third phase, the MBM was preferred when compared to the 2011 Survey Criteria for Fibromyalgia WPI (Table 2).  There were no differences in participant preferences between the MBM and BPI (Table 2).

Conclusion

Overall, participants demonstrated good understanding of the MBM and preferred it to the WPI from the Fibromyalgia Survey Criteria.  When compared to the BPI body map, the MBM offers advantages in quantifying, as there is no ambiguity as to the area that was checked.  Some participants confused right and left in the MBM and body areas tended to be underreported when compared to verbally assessing each of the 35 possible body areas individually.

Table 1. First phase: Assessment of understanding

N (%)

Identified right/left correctly

     Yes

16 (64%)

     No

5 (20%)

     Missing

4 (16%)

Pain present for 3 months or more

     Yes

19 (76%)

     No

1 (4%)

     Missing

5 (20%)

Able to indicate all areas of pain

     Yes

21 (84%)

     No

4 (16%)

Table 2. Third phase: Questionnaire preference

MBM vs. BPI

MBM vs. WPI

MBM

BPI

MBM

WPI

Preference

45%

45%

70%

15%

Best depicts areas of pain

30%

55%

70%

5%

Easier to complete

20%

40%

50%

30%

Best distinguishes left from right

20%

40%

45%

25%



Disclosure:

C. M. Brummett,
None;

J. Goesling,
None;

R. Bakshi,
None;

J. Wolfe,
None;

S. Moser,
None;

D. A. Williams,

Pfizer, Inc,

2;

A. L. Hassett,

Pfizer Inc,

2,

Bristol-Myers Squibb,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/preliminary-validation-of-the-michigan-body-map/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology